Skip to main content
. 2024 Mar 12;8:43. doi: 10.1186/s41747-024-00448-y

Table 2.

Comparisons of diffusion-weighted imaging parameters among four groups

Parameters (mean ± SD) BS group (n = 5) B group (n = 6) S group (n = 5) C group (n = 6) χ2 p
Dt(×10-3 mm2/s) 0.599 ± 0.116 0.530 ± 0.067 0.519 ± 0.068 0.475 ± 0.034 5.739 0.125
Dp(×10-3 mm2/s) 6.114 ± 3.782 9.071 ± 5.513 11.848 ± 5.092 13.988 ± 5.174 6.580 0.087
f 0.016 ± 0.009 0.018 ± 0.009 0.024 ± 0.017 0.038 ± 0.010 8.910 0.031
MD(×10-3 mm2/s) 0.695 ± 0.173 0.596 ± 0.094 0.534 ± 0.103 0.505 ± 0.038 9.502 0.023
MK 0.665 ± 0.132 0.903 ± 0.155 1.016 ± 0.191 1.020 ± 0.123 10.375 0.016
DDC(×10-3 mm2/s) 0.524 ± 0.079 0.459 ± 0.047 0.456 ± 0.067 0.420 ± 0.018 7.523 0.057
α 0.912 ± 0.023 0.887 ± 0.028 0.865 ± 0.046 0.853 ± 0.023 9.002 0.029
D(×10-3 mm2/s) 0.432 ± 0.043 0.399 ± 0.024 0.398 ± 0.047 0.390 ± 0.042 3.169 0.366
β 0.932 ± 0.026 0.906 ± 0.022 0.884 ± 0.036 0.871 ± 0.039 9.739 0.021
µ(μm) 5.962 ± 1.130 5.745 ± 0.766 5.766 ± 1.035 4.297 ± 1.540 6.795 0.079

Significant results reported in bold characters. Data are expressed as mean ± SD. B Bufalin treatment, BS Bufalin plus sorafenib treatment, C Control, DDC Distributed diffusion coefficient, MD Mean diffusivity, MK Mean kurtosis, S Sorafenib treatment, SD Standard deviation